123 related articles for article (PubMed ID: 34565234)
21. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.
Jarrin I; Suarez-Garcia I; Moreno C; Tasias M; Del Romero J; Palacios R; Peraire J; Gorgolas M; Moreno S;
Antivir Ther; 2019; 24(3):167-175. PubMed ID: 30747107
[TBL] [Abstract][Full Text] [Related]
22. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
23. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
Yanik EL; Achenbach CJ; Gopal S; Coghill AE; Cole SR; Eron JJ; Moore RD; Mathews WC; Drozd DR; Hamdan A; Ballestas ME; Engels EA
J Clin Oncol; 2016 Sep; 34(27):3276-83. PubMed ID: 27507879
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.
Alejos B; Suárez-García I; Rava M; Bautista-Hernández A; Gutierrez F; Dalmau D; Sagastagoitia I; Rivero A; Moreno S; Jarrín I;
J Antimicrob Chemother; 2020 Oct; 75(10):3004-3014. PubMed ID: 32667674
[TBL] [Abstract][Full Text] [Related]
25. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
26. Mucocutaneous Manifestations of People Living with HIV in Current Antiretroviral Therapy Era.
Sivaz O; Ozkur E; Altunay IK; Oncul A; Sevgi DY
Curr HIV Res; 2022 Aug; 20(2):120-128. PubMed ID: 35236269
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count.
Acharya S; Ross JD
Int J STD AIDS; 2007 Jul; 18(7):499-500. PubMed ID: 17623511
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of 255 HIV/AIDS cases: Hacettepe cohort, Ankara, Turkey].
Çerçi P; İnkaya AÇ; Alp Ş; Tümer A; Ünal S
Mikrobiyol Bul; 2016 Jan; 50(1):94-103. PubMed ID: 27058333
[TBL] [Abstract][Full Text] [Related]
30. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Mani D; Neil N; Israel R; Aboulafia DM
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
[TBL] [Abstract][Full Text] [Related]
31. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
32. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
33. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival.
Brodt HR; Kamps BS; Helm EB; Schöfer H; Mitrou P
AIDS; 1998 Aug; 12(12):1475-81. PubMed ID: 9727568
[TBL] [Abstract][Full Text] [Related]
35. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
36. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China.
Li YY; Yang SH; Wang RR; Tang JT; Wang HM; Kuang YQ
Int J Dermatol; 2020 Mar; 59(3):308-313. PubMed ID: 31846069
[TBL] [Abstract][Full Text] [Related]
37. Early syphilis affects markers of HIV infection.
Kotsafti O; Paparizos V; Kourkounti S; Chatziioannou A; Nicolaidou E; Kapsimali V; Antoniou C
Int J STD AIDS; 2016 Aug; 27(9):739-45. PubMed ID: 26113517
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
39. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
40. Dermatoses among Brazilian HIV-positive patients: correlation with the evolutionary phases of AIDS.
Rosatelli JB; Machado AA; Roselino AM
Int J Dermatol; 1997 Oct; 36(10):729-34. PubMed ID: 9372345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
